Accepted answer
96.4 and 98.8 are 2.4 percentage points apart, which sounds small until you restate it as impurity. PeptideMeter is leaving 3.6 per cent of the detected area unassigned and Janoshik 1.2 per cent — a factor of 3 between them. The impurity fraction is the quantity that moves when a method changes, and it is the one worth arguing about; the headline is just its complement. Comparable means same column chemistry, same gradient slope, same detection wavelength, same integration convention. Until you have those four from both laboratories, 96.4 and 98.8 are two measurements of slightly different quantities that happen to share a unit.
The underlying point is that purity is a method-dependent figure, and that is not a limitation of the measurement, it is a property of what the measurement actually answers.
The fraction of your main peak that is actually your target versus isomers, fragments or related sequences is invisible without complementary identity testing.
Mobile phase additive choice affects ionisation and peak shape — TFA gives sharp peaks but suppresses mass spectrometry signal, formic acid gives worse peaks but preserves signal.
Published side-by-side method comparisons show that a two-point difference in purity on the same vial is easily explained by method choice alone.
Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.
The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.
edited 30 Jul 2026 by a_lindgren — reworded for clarity after a comment
Worth adding that the method section is where the answer usually is. – rhian_prydderch 5 months ago add a comment